Cannabis: maxistudio clinical study to use it against cancer and boost the immune system



[ad_1]

Can you take cannabis to prevent or delay cancer recurrence and strengthen the immune system? The largest clinical study ever conducted on the subject has been launched in Germany. This was announced by scientists at the Medical Center of the University of Rostock in Germany who claimed the benefits after a review of more than 100 studies, the world's largest clinical trial to find out if cannabis can prevent tumors . showed that cannabis compounds can help reduce the side effects of cancer treatments such as nausea and disease. The latest study, published in the British Journal of Pharmacology, revealed that phytocannabinoids – the most important compound in cannabis – may be responsible for the direct fight against cancer cells . The researchers say that the human endocannabinoid system, responsible for brain function, endocrine function, and immune tissue, can be positively stimulated by phytocannabinoids.

Compounds are the most notable type of "cannabinoids", and are naturally present in cannabis plant, an example is tetrahydrocannabinol, or THC, which gives the plant its psychoactive properties and increases the size of users. This particular compound is monitored as a marker of the potency of plants in areas of the world where cannabis is legal. Studies have shown that cannabinoids can prevent cancer cells from dividing and invading normal tissues and can block blood supply to tumors.

Some studies also indicate that cannabinoids can enhance the body's immune response against the growth and spread of tumors. Previous study data have suggested that cannabinoids have effects on different levels of cancer progression, including tumor cell proliferation, invasion, and chemoresistance. The researchers observed continuity across the wide range of studies, which showed that cannabis compounds can actively fight cancer cells.

The author of the study, Professor Burkhard Hinz, said: still need more anti-cancer drugs. "In this context, the accumulation of data from preclinical models suggests that cannabinoids cause anti-cancer effects on different levels of cancer progression." Clinical studies are urgent to study the impact of cannabinoids on growth and the progression of tumors in patients. "

Share this article:

[ad_2]
Source link